Skip to content
★ Sign in to follow
CH

CardioGenics Holdings Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by STERLING LINDA J., was filed 11 Feb 2015.

CardioGenics Holdings Inc.: what insiders have been doing

CardioGenics Holdings Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). CardioGenics Holdings Inc. has had no insider filing for more than a year; the last one goes back to 11 February 2015.

Looking back to 2010, when coverage begins, insiders filed 7 purchases and no sales.

Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
7
Thresholds
n/a
Buy Volume
€615,029
7 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

  • Filed 11 Feb 2015 · 4288 days ago · €27k
    +26.7%
    Entry US$0.02 · Close at T+365 US$0.03
  • Filed 11 Feb 2015 · 4288 days ago · €93k
    +26.7%
    Entry US$0.02 · Close at T+365 US$0.03
  • Filed 11 Feb 2015 · 4288 days ago · €23k
    +26.7%
    Entry US$0.02 · Close at T+365 US$0.03

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Financial data

· cache

US$0.00
Analyst consensus
·
Income statement
EBITDA-US$753.6k
Valuation
Beta68.39
Profitability & ownership
ROA-115.5%
% insiders2.5%
% institutions0.0%
Last declaration on 11 February 2015
Declarations7 total
  • ▲
    SECRETARYExecutives
    30,928 USD0SEC
    281,162 shares@ US$0.11Common StockSEC:0001493152-15-000448:0
    Canonical exit: 6 May 2015 (T+90)
  • ▲
    DirectorExecutives
    105,494 USD0SEC
    959,039 shares@ US$0.11Common StockSEC:0001493152-15-000449:0
    Canonical exit: 6 May 2015 (T+90)
  • ▲
    CHIEF FINANCIAL OFFICERExecutives
    25,773 USD0SEC
    234,302 shares@ US$0.11Common StockSEC:0001493152-15-000447:0
    Canonical exit: 6 May 2015 (T+90)
  • ▲
    CHIEF FINANCIAL OFFICERExecutives
    25,000 USD0SEC
    227,273 shares@ US$0.11Common StockSEC:0001493152-15-000447:1
    Canonical exit: 6 May 2015 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    208,587 USD0SEC
    1,896,246 shares@ US$0.11Common StockSEC:0001493152-15-000450:0
    Canonical exit: 6 May 2015 (T+90)
  • ▲
    DirectorExecutives
    50,000 USD0SEC
    50,000 shares@ US$1.00Common SharesSEC:0001144204-11-007733:0
    Canonical exit: 9 May 2011 (T+90)
  • ▲
    DirectorExecutives
    300,000 USD0SEC
    600,000 shares@ US$0.50Common SharesSEC:0001144204-10-064527:0
    Canonical exit: 2 Mar 2011 (T+90)

7 of 7 declarations

About CardioGenics Holdings Inc.

CardioGenics Holdings Inc. is a company focused on developing diagnostic technologies for cardiovascular diseases. It is listed on NASDAQ under the symbol CGNH.